Sage Therapeutics (NASDAQ:SAGE) shares are trading higher after the company announced it received Fast Track Designation for SAGE-718 or the treatment of Huntington’s disease.
Sage Therapeutics is currently up 3.42% to a price of $45.09. Wednesday the stock has been traded at a volume of 393.70 thousand, about 67.2% of its recent 30-day volume average of 585.88 thousand.
The 50-day moving average price of Sage Therapeutics’s stock was $45.56 when this article was published. The stock reached a high of $98.39 and a low of $39.77 in the past 52 weeks.
Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.
